All Stories

  1. Atherogenic Index of Plasma and Residual Risk in Anticoagulated Patients With Atrial Fibrillation: The Prospective Murcia Atrial Fibrillation Project III Cohort

    Article • Journal of the American Heart Association, March 2026, Wolters Kluwer Health

    Prof. Francisco Marin

  2. Guiding Surgical Haemostasis in Inherited Factor VII Deficiency: Looking beyond Coagulation Factor Levels

    Article • Thrombosis and Haemostasis, February 2026, Thieme Publishing Group

    Prof. Francisco Marin

  3. The Long-Term Outcomes of Corticosteroid Use in COVID-19 Patients with Cardiovascular Disease: A Propensity-Matched Analysis from the Multi-Center International Prospective Registry (HOPE-2)

    Article • Biomedicines, October 2025, MDPI AG

    Prof. Francisco Marin

  4. Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, August 2025, Oxford University Press (OUP)

    Prof. Francisco Marin

  5. Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation

    Article • European Journal of Preventive Cardiology, May 2025, Oxford University Press (OUP)

    Prof. Francisco Marin

  6. Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry

    Article • Journal of the American Heart Association, January 2025, Wolters Kluwer Health

    Prof. Francisco Marin , Nika Kuridze

  7. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Article • Journal of Clinical Medicine, April 2024, MDPI AG

    Prof. Francisco Marin

  8. Reducing bleeding risk in patients on oral anticoagulation therapy

    Article • Expert Review of Cardiovascular Therapy, November 2023, Taylor & Francis

    Prof. Francisco Marin

  9. Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment

    Article • Medicina Clínica, October 2023, Elsevier

    Prof. Francisco Marin

  10. Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved

    Article • Thrombosis and Haemostasis, September 2023, Thieme Publishing Group

    Prof. Francisco Marin

  11. Reticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases

    Article • Thrombosis and Haemostasis, September 2023, Thieme Publishing Group

    Prof. Francisco Marin

  12. Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment

    Article • The American Journal of Cardiology, September 2023, Elsevier

    Prof. Francisco Marin

  13. Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in “real world”: the REQXAA study

    Article • Revista Española de Cardiología (English Edition), September 2023, Elsevier

    Prof. Francisco Marin

  14. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

    Article • The Science of The Total Environment, July 2023, Elsevier

    Prof. Francisco Marin

  15. Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients

    Article • IJC Heart & Vasculature, June 2023, Elsevier

    Prof. Francisco Marin

  16. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Article • Frontiers in Endocrinology, May 2023, Frontiers

    Prof. Francisco Marin

  17. Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia

    Article • Heart & Lung, May 2023, Elsevier

    Prof. Francisco Marin

  18. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

    Article • The FASEB Journal, April 2023, Wiley

    Prof. Francisco Marin

  19. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

    Article • Journal of Clinical Medicine, April 2023, MDPI AG

    Prof. Francisco Marin , Miss Clarissa Giebel

  20. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    Article • American Heart Journal, April 2023, Elsevier

    Prof. Francisco Marin

  21. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

    Article • Journal of Comparative Effectiveness Research, March 2023, Becaris Publishing Limited

    Prof. Francisco Marin

  22. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

    Article • Biomedicine & Pharmacotherapy, February 2023, Elsevier

    Prof. Francisco Marin

  23. Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis

    Article • European Journal of Internal Medicine, February 2023, Elsevier

    Prof. Francisco Marin

  24. Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients

    Article • Journal of Clinical Medicine, January 2023, MDPI AG

    Prof. Francisco Marin

  25. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Article • Journal of Clinical Medicine, January 2023, MDPI AG

    Prof. Francisco Marin

  26. Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis

    Article • Internal and Emergency Medicine, January 2023, Springer Science + Business Media

    Prof. Francisco Marin

  27. Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry

    Article • European Journal of Internal Medicine, January 2023, Elsevier

    Prof. Francisco Marin , Nika Kuridze

  28. Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey

    Article • EP Europace, December 2022, Oxford University Press (OUP)

    Prof. Francisco Marin , Dr Radoslaw Lenarczyk

  29. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

    Article • Cardiology Journal, December 2022, VM Media SP. zo.o VM Group SK

    Prof. Francisco Marin

  30. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Article • EP Europace, November 2022, Oxford University Press (OUP)

    Prof. Francisco Marin , Nika Kuridze

  31. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry

    Article • European Journal of Internal Medicine, November 2022, Elsevier

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  32. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries

    Article • Journal of Comparative Effectiveness Research, November 2022, Becaris Publishing Limited

    Prof. Francisco Marin

  33. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, November 2022, Oxford University Press (OUP)

    Prof. Francisco Marin

  34. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system

    Article • Frontiers in Cardiovascular Medicine, October 2022, Frontiers

    Prof. Francisco Marin

  35. Polypill Strategy in Secondary Cardiovascular Prevention

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2022, New England Journal of Medicine (NEJM/MMS)

    Prof HECTOR BUENO, MD, PhD ANTONIO PORTOLES, Prof. Francisco Marin , Prof. Vicente Andrés, Professor Deepak L Bhatt

  36. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    Article • BMC Medicine, September 2022, Springer Science + Business Media

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  37. Predicting heart failure in atrial fibrillation patients: What about using biomarkers?

    Article • American Heart Journal, September 2022, Elsevier

    Prof. Francisco Marin

  38. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Article • Expert Opinion on Pharmacotherapy, August 2022, Taylor & Francis

    Prof. Francisco Marin

  39. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

    Article • Age and Ageing, August 2022, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  40. Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program

    Article • Medicina Clínica, August 2022, Elsevier

    Prof. Francisco Marin

  41. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

    Article • Journal of Personalized Medicine, July 2022, MDPI AG

    Prof. Francisco Marin

  42. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper

    Article • Thrombosis and Haemostasis, July 2022, Thieme Publishing Group

    Prof. Francisco Marin

  43. Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry

    Article • Journal of the American Heart Association, July 2022, Wolters Kluwer Health

    Prof. Francisco Marin

  44. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

    Article • Cardiology Journal, July 2022, VM Media SP. zo.o VM Group SK

    Prof. Francisco Marin

  45. Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation ...

    Article • European Journal of Preventive Cardiology, June 2022, Oxford University Press (OUP)

    Nika Kuridze, Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  46. Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry

    Article • European Journal of Preventive Cardiology, June 2022, Oxford University Press (OUP)

    Professor Erkin Mirrakhimov, Prof. Francisco Marin , Lucia Cojocaru

  47. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    Article • International Journal of Clinical Practice, May 2022, Hindawi Publishing Corporation

    Prof. Francisco Marin

  48. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry

    Article • Frontiers in Cardiovascular Medicine, May 2022, Frontiers

    Prof. Francisco Marin

  49. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

    Article • European Journal of Internal Medicine, May 2022, Elsevier

    Nika Kuridze, Professor Tchavdar N Shalganov, Prof. Francisco Marin

  50. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

    Article • European Journal of Internal Medicine, May 2022, Elsevier

    Nika Kuridze, Prof. Francisco Marin

  51. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

    Article • European Journal of Clinical Investigation, April 2022, Wiley

    Prof. Francisco Marin

  52. The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

    Article • Journal of General Internal Medicine, April 2022, Springer Science + Business Media

    Prof. Francisco Marin

  53. Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients

    Article • European Journal of Internal Medicine, April 2022, Elsevier

    Prof. Francisco Marin

  54. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry

    Article • European Journal of Clinical Investigation, March 2022, Wiley

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  55. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascul...

    Article • EP Europace, March 2022, Oxford University Press (OUP)

    Prof. Francisco Marin

  56. Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists

    Article • Journal of Personalized Medicine, March 2022, MDPI AG

    Prof. Francisco Marin

  57. Clinical implications of diabetes mellitus in patients with acute coronary syndrome: Prognostic role and use of new P2Y12 receptor inhibitors

    Article • Diabetes Research and Clinical Practice, February 2022, Elsevier

    Prof. Francisco Marin

  58. Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry

    Article • European Journal of Clinical Investigation, January 2022, Wiley

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  59. Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation

    Article • Clinical Research in Cardiology, January 2022, Springer Science + Business Media

    Prof. Francisco Marin

  60. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2021, New England Journal of Medicine (NEJM/MMS)

    Prof. Francisco Marin

  61. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Article • EP Europace, November 2021, Oxford University Press (OUP)

    Nika Kuridze, Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  62. Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP‐AF Long‐term General Registry

    Article • European Journal of Clinical Investigation, November 2021, Wiley

    Prof. Francisco Marin

  63. Impact of sex differences and network systems on the in-hospital mortality of patients with ST-segment elevation acute myocardial infarction

    Article • Revista Española de Cardiología (English Edition), November 2021, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  64. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    Article • BMC Medicine, October 2021, Springer Science + Business Media

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  65. Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC–EHRA EORP AF Long-Term General Registry

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, October 2021, Oxford University Press (OUP)

    Nika Kuridze, Prof. Francisco Marin

  66. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

    Article • Frontiers in Medicine, October 2021, Frontiers

    Prof. Francisco Marin

  67. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

    Article • Heart, October 2021, BMJ

    Prof. Francisco Marin

  68. Relationship between multimorbidity and outcomes in atrial fibrillation

    Article • Experimental Gerontology, October 2021, Elsevier

    Prof. Francisco Marin

  69. Prognosis Impact of Diabetes in Elderly Women and Men with Non-ST Elevation Acute Coronary Syndrome

    Article • Journal of Clinical Medicine, September 2021, MDPI AG

    Dr Gonzalo L Alonso Salinas, Prof. Francisco Marin

  70. Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

    Article • Cardiovascular Diabetology, September 2021, Springer Science + Business Media

    Prof. Francisco Marin

  71. Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

    Article • Thrombosis Research, September 2021, Elsevier

    Prof. Francisco Marin

  72. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Article • Revista Española de Cardiología (English Edition), September 2021, Elsevier

    Prof. Francisco Marin

  73. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

    Article • Clinical Research in Cardiology, August 2021, Springer Science + Business Media

    Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  74. COVID‐19 and the impact of arterial hypertension—An analysis of the international HOPE COVID‐19 Registry (Italy‐Spain‐Germany)

    Article • European Journal of Clinical Investigation, August 2021, Wiley

    Prof. Francisco Marin

  75. Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry

    Article • EP Europace, August 2021, Oxford University Press (OUP)

    Prof. Francisco Marin

  76. Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS

    Article • Journal of Clinical Medicine, July 2021, MDPI AG

    Prof. Francisco Marin

  77. Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence

    Article • British Journal of Clinical Pharmacology, July 2021, Wiley

    Prof. Francisco Marin

  78. In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide Spanish database

    Article • Cardiology Journal, July 2021, VM Media SP. zo.o VM Group SK

    Prof HECTOR BUENO, Prof. Francisco Marin

  79. Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

    Article • International Journal of Molecular Sciences, July 2021, MDPI AG

    Prof. Francisco Marin

  80. Fibrilación auricular en pacientes con COVID-19. Utilidad de la puntuación CHA2DS2-VASc: un análisis del registro internacional HOPE COVID-19

    Article • Revista Española de Cardiología, July 2021, Elsevier

    Prof. Francisco Marin

  81. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Article • Revista Española de Cardiología (English Edition), July 2021, Elsevier

    Prof. Francisco Marin

  82. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry

    Article • EP Europace, June 2021, Oxford University Press (OUP)

    Prof. Francisco Marin

  83. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation

    Article • Revista Española de Cardiología (English Edition), May 2021, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  84. Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)

    Article • Journal of Comparative Effectiveness Research, May 2021, Becaris Publishing Limited

    Prof. Francisco Marin

  85. Underlying heart diseases and acute COVID-19 outcomes

    Article • Cardiology Journal, April 2021, VM Media SP. zo.o VM Group SK

    Prof. Francisco Marin

  86. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

    Article • Critical Care Medicine, April 2021, Wolters Kluwer Health

    Prof. Francisco Marin

  87. Baseline CHA 2 DS 2 ‐VASc score and prognosis in octogenarians with non‐ST segment elevation acute coronary syndrome

    Article • International Journal of Clinical Practice, March 2021, Hindawi Publishing Corporation

    Prof HECTOR BUENO, Prof. Francisco Marin

  88. Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

    Article • Diabetes Care, March 2021, American Diabetes Association

    Prof. Francisco Marin , Professor Deepak L Bhatt

  89. Sex bias in admission to tertiary‐care centres for acute myocardial infarction and cardiogenic shock

    Article • European Journal of Clinical Investigation, March 2021, Wiley

    Prof HECTOR BUENO, Prof. Francisco Marin

  90. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

    Article • Infection, March 2021, Springer Science + Business Media

    Prof. Francisco Marin

  91. Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes

    Article • European Journal of Clinical Investigation, February 2021, Wiley

    Prof HECTOR BUENO, Prof. Francisco Marin

  92. Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications

    Article • Journal of Clinical Medicine, February 2021, MDPI AG

    Prof. Francisco Marin

  93. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry

    Article • February 2021, Research Square

    Prof. Francisco Marin

  94. Novel insights in the relationship of gut microbiota and coronary artery diseases

    Article • Critical Reviews in Food Science and Nutrition, January 2021, Taylor & Francis

    Prof. Francisco Marin

  95. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience from the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

    Article • SSRN Electronic Journal, January 2021, Elsevier

    Prof. Francisco Marin

  96. Outcomes in VKA‐treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real‐world’

    Article • International Journal of Clinical Practice, December 2020, Hindawi Publishing Corporation

    Prof. Francisco Marin

  97. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing an...

    Article • EP Europace, December 2020, Oxford University Press (OUP)

    Prof. Francisco Marin

  98. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores

    Article • Thrombosis and Haemostasis, December 2020, Thieme Publishing Group

    Prof. Francisco Marin

  99. Factor XI, much more than an innocent observer

    Article • Journal of Thrombosis and Haemostasis, December 2020, Elsevier

    Prof. Francisco Marin

  100. Influence of the matrix type over the concentration of GDF-15

    Article • Journal of Investigative Medicine, December 2020, SAGE Publications

    Prof. Francisco Marin

  101. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis

    Article • Frontiers in Endocrinology, November 2020, Frontiers

    Prof. Francisco Marin

  102. Incidence and outcomes of hospital treated acute myocarditis from 2003 to 2015 in Spain

    Article • European Journal of Clinical Investigation, November 2020, Wiley

    Prof HECTOR BUENO, Prof. Francisco Marin

  103. Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

    Article • Journal of Clinical Medicine, November 2020, MDPI AG

    Prof. Francisco Marin

  104. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Article • Internal and Emergency Medicine, November 2020, Springer Science + Business Media

    Prof. Francisco Marin

  105. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID‐19

    Article • European Journal of Clinical Investigation, November 2020, Wiley

    Prof. Francisco Marin

  106. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry

    Article • European Journal of Clinical Investigation, November 2020, Wiley

    Prof. Francisco Marin

  107. Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation

    Article • Mayo Clinic Proceedings, November 2020, Elsevier

    Prof. Francisco Marin

  108. Impacto del tratamiento antitrombótico y los síndromes geriátricos en octogenarios con fibrilación auricular y cardiopatía isquémica. Fibrilación Auricular y Cardiopatía Isquémica en Longevos (FACIL)

    Article • Revista Española de Geriatría y Gerontología, November 2020, Elsevier

    Prof. Francisco Marin

  109. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

    Article • EP Europace, October 2020, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  110. Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response

    Article • Expert Review of Precision Medicine and Drug Development, September 2020, Taylor & Francis

    Prof. Francisco Marin

  111. Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

    Article • Revista Española de Cardiología (English Edition), September 2020, Elsevier

    Prof. Francisco Marin

  112. Recomendaciones sobre el tratamiento antitrombótico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología

    Article • Revista Española de Cardiología, September 2020, Elsevier

    Prof. Francisco Marin

  113. Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial

    Article • European Heart Journal, August 2020, Oxford University Press (OUP)

    Prof. Francisco Marin

  114. A nurse‐led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes

    Article • International Journal of Clinical Practice, August 2020, Hindawi Publishing Corporation

    Prof. Francisco Marin

  115. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study

    Article • European Journal of Internal Medicine, August 2020, Elsevier

    Prof. Francisco Marin

  116. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy

    Article • Expert Opinion on Pharmacotherapy, July 2020, Taylor & Francis

    Prof. Francisco Marin

  117. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry

    Article • Journal of Nephrology, June 2020, Springer Science + Business Media

    Prof. Francisco Marin

  118. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

    Article • Annals of Medicine, June 2020, Taylor & Francis

    Prof. Francisco Marin

  119. Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

    Article • Thrombosis and Haemostasis, June 2020, Thieme Publishing Group

    Prof. Francisco Marin

  120. Comments on the 2019 ESC guidelines on chronic coronary syndromes

    Article • Revista Española de Cardiología (English Edition), June 2020, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  121. Comments on the 2019 ESC guidelines on acute pulmonary embolism

    Article • Revista Española de Cardiología (English Edition), June 2020, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin , Luis Jara-Palomares

  122. Comments on the 2019 ESC guidelines on supraventricular tachycardia

    Article • Revista Española de Cardiología (English Edition), June 2020, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  123. FRAIL Scale also Predicts Long-Term Outcomes in Older Patients With Acute Coronary Syndromes

    Article • Journal of the American Medical Directors Association, May 2020, Elsevier

    Prof. Francisco Marin

  124. Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice

    Article • Revista Española de Cardiología (English Edition), April 2020, Elsevier

    Prof. Francisco Marin

  125. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, March 2020, SAGE Publications

    Prof. Francisco Marin

  126. Comments on the 2019 ESC guidelines on diabetes, prediabetes, and cardiovascular disease

    Article • Revista Española de Cardiología (English Edition), March 2020, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  127. Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias

    Article • Revista Española de Cardiología (English Edition), March 2020, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  128. Early Small Creatinine Shift Predicts Contrast-Induced Acute Kidney Injury and Persistent Renal Damage after Percutaneous Coronary Procedures

    Article • Cardiovascular Revascularization Medicine, March 2020, Elsevier

    Prof. Francisco Marin

  129. One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

    Article • British Journal of Clinical Pharmacology, February 2020, Wiley

    Prof. Francisco Marin

  130. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry

    Article • Journal of the American Heart Association, January 2020, Wolters Kluwer Health

    Prof. Francisco Marin

  131. Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

    Article • BMJ Open, December 2019, BMJ

    Prof. Francisco Marin

  132. ‘Real-world’ observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin Ame...

    Article • EP Europace, November 2019, Oxford University Press (OUP)

    Prof. Francisco Marin

  133. Are There Gaps in the Evidence on the Treatment of Mild Hypertension in Patients With Low Cardiovascular Risk? Response

    Article • Revista Española de Cardiología (English Edition), October 2019, Elsevier

    Prof. Francisco Marin

  134. Optimized scoring tool to quantify the functional performance during the sit-to-stand transition with a magneto-inertial measurement unit

    Article • Clinical Biomechanics, October 2019, Elsevier

    Prof. Francisco Marin

  135. Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey

    Article • EP Europace, September 2019, Oxford University Press (OUP)

    Prof. Francisco Marin , Dr Radoslaw Lenarczyk

  136. The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

    Article • Thrombosis and Haemostasis, September 2019, Thieme Publishing Group

    Prof. Francisco Marin

  137. High-sensitivity microsatellite instability assessment for the detection of mismatch repair defects in normal tissue of biallelic germline mismatch repair mutation carriers

    Article • Journal of Medical Genetics, September 2019, BMJ

    Pilar Guerra-Garcia, Prof. Francisco Marin

  138. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Article • Revista Española de Cardiología (English Edition), September 2019, Elsevier

    Dr Gonzalo L Alonso Salinas, Prof. Francisco Marin

  139. Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

    Article • Journal of Bone and Mineral Research, August 2019, Oxford University Press (OUP)

    Prof. Francisco Marin

  140. A colorimetric method for the determination of different functional flavonoids using 2,2'-azino-bis-(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) and peroxidase

    Article • Preparative Biochemistry & Biotechnology, August 2019, Taylor & Francis

    Prof. Francisco Marin

  141. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Article • The Lancet Diabetes & Endocrinology, August 2019, Elsevier

    Professor Thomas Munzel or Muenzel, Prof. Francisco Marin , Professor Deepak L Bhatt

  142. Optimal marker set assessment for motion capture of 3D mimic facial movements

    Article • Journal of Biomechanics, August 2019, Elsevier

    Prof. Francisco Marin

  143. Epidemiology of Cardiac Myxoma in a Spanish Population. A 30-year Surgical Series

    Article • Revista Española de Cardiología (English Edition), August 2019, Elsevier

    Prof. Francisco Marin

  144. Antisynthetase Syndrome and Autoantibodies: A Literature Review and Report of 4 Cases

    Article • American Journal of Case Reports, July 2019, International Scientific Literature

    Prof. Francisco Marin

  145. Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease

    Article • Minerva Medica, July 2019, Edizioni Minerva Medica

    Prof. Francisco Marin

  146. Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study

    Article • PLOS One, June 2019, PLOS

    Prof. Francisco Marin

  147. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

    Article • Stroke, June 2019, Wolters Kluwer Health

    Prof. Francisco Marin

  148. Performance of alternative measures to body mass index in the assessment of moderate and severe under-nutrition among acutely unwell patients hospitalized in a TB ward in the Philippines: A cross-sectional study

    Article • PLOS One, May 2019, PLOS

    Prof. Francisco Marin

  149. Devices for mechanical circulatory support and strategies for their management in cardiogenic shock

    Article • Kardiologia Polska, May 2019, Polskie Towarzystwo Kardiologiczne

    Prof. Francisco Marin

  150. 'Palaeoshellomics’ reveals the use of freshwater mother-of-pearl in prehistory

    Article • eLife, May 2019, eLife

    Prof. Francisco Marin

  151. Mitral Regurgitation and Prognosis After Non‐ST‐Segment Elevation Myocardial Infarction in Very Old Patients

    Article • Journal of the American Geriatrics Society, May 2019, Wiley

    Prof HECTOR BUENO, Prof. Francisco Marin

  152. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

    Article • Thrombosis Journal, April 2019, Springer Science + Business Media

    Prof. Francisco Marin

  153. Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

    Article • Scientific Reports, April 2019, Springer Science + Business Media

    Prof. Francisco Marin

  154. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome

    Article • European Journal of Internal Medicine, April 2019, Elsevier

    Prof HECTOR BUENO, Francesc Formiga, Prof. Francisco Marin

  155. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey

    Article • EP Europace, March 2019, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk, Prof. Francisco Marin

  156. High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention

    Article • Thrombosis Research, March 2019, Elsevier

    Prof. Francisco Marin

  157. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome

    Article • European Journal of Internal Medicine, March 2019, Elsevier

    Prof. Francisco Marin

  158. Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis

    Article • Bone, March 2019, Elsevier

    Prof. Francisco Marin

  159. Comments on the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy

    Article • Revista Española de Cardiología (English Edition), February 2019, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  160. Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension

    Article • Revista Española de Cardiología (English Edition), February 2019, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  161. Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

    Article • Revista Española de Cardiología (English Edition), February 2019, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  162. Toward mechanistic models for genotype–phenotype correlations in phenylketonuria using protein stability calculations

    Article • Human Mutation, January 2019, Hindawi Publishing Corporation

    Prof. Francisco Marin

  163. Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

    Article • Journal of Bone and Mineral Research, January 2019, Oxford University Press (OUP)

    Prof. Francisco Marin

  164. Diabetes mellitus, frailty and prognosis in very elderly patients with acute coronary syndromes

    Article • Aging Clinical and Experimental Research, January 2019, Springer Science + Business Media

    Prof HECTOR BUENO, Prof. Francisco Marin

  165. A voxel-based method for designing a numerical biomechanical model patient-specific with an anatomical functional approach adapted to additive manufacturing

    Article • Computer Methods in Biomechanics & Biomedical Engineering, January 2019, Taylor & Francis

    Prof. Francisco Marin

  166. Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial

    Article • Archives of Osteoporosis, January 2019, Springer Science + Business Media

    Prof. Francisco Marin

  167. Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis

    Article • Clinical Drug Investigation, January 2019, Springer Science + Business Media

    Prof. Francisco Marin

  168. OUP accepted manuscript

    Article • EP Europace, January 2019, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  169. Statin Treatment and Prognosis of Elderly Patients Discharged after Non-ST Segment Elevation Acute Coronary Syndrome

    Article • Cardiology, January 2019, Karger Publishers

    Prof HECTOR BUENO, Prof. Francisco Marin

  170. Comments on the 2018 ESC Fourth Universal Definition of Myocardial Infarction

    Article • Revista Española de Cardiología (English Edition), January 2019, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  171. Comments on the 2018 ESC/EACTS Guidelines for Myocardial Revascularization

    Article • Revista Española de Cardiología (English Edition), January 2019, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  172. Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test

    Article • Circulation Cardiovascular Interventions, December 2018, Wolters Kluwer Health

    Prof. Francisco Marin

  173. Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines

    Article • PLOS One, November 2018, PLOS

    Prof. Francisco Marin

  174. Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS)

    Article • Current Medical Research and Opinion, November 2018, Taylor & Francis

    Dr Chung-Hwan Chen, Abdulaziz Elsalmawy, Prof. Francisco Marin

  175. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2018, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt, Dr Tuomas O Kiviniemi, Professor Thomas Munzel or Muenzel, Prof. Francisco Marin

  176. Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies

    Article • Bone, November 2018, Elsevier

    Prof. Francisco Marin

  177. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists

    Article • QJM, October 2018, Oxford University Press (OUP)

    Prof. Francisco Marin

  178. A multi‐layered nerve guidance conduit design adapted to facilitate surgical implantation

    Article • Health Science Reports, October 2018, Wiley

    Prof. Francisco Marin

  179. Reduction of Hip and Other Fractures in Patients Receiving Teriparatide in Real-World Clinical Practice: Integrated Analysis of Four Prospective Observational Studies

    Article • Calcified Tissue International, October 2018, Springer Science + Business Media

    Prof. Francisco Marin

  180. Identification of Noise Covariance Matrices to Improve Orientation Estimation by Kalman Filter

    Article • Sensors, October 2018, MDPI AG

    Prof. Francisco Marin

  181. Comments on the 2018 ESC Guidelines for the Diagnosis and Management of Syncope

    Article • Revista Española de Cardiología (English Edition), October 2018, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  182. Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores

    Article • Journal of the American Heart Association, September 2018, Wolters Kluwer Health

    María Asunción Esteve-Pastor, Dr Marco Proietti, Prof. Francisco Marin

  183. Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

    Article • The Journal of Clinical Pharmacology, September 2018, Wiley

    María Asunción Esteve-Pastor, Prof. Francisco Marin

  184. Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated “Real-World” in Patients With Atrial Fibrillation

    Article • The American Journal of Cardiology, September 2018, Elsevier

    Prof. Francisco Marin

  185. Biochemical characterization of the skeletal matrix of the massive coral, Porites australiensis – The saccharide moieties and their localization

    Article • Journal of Structural Biology, September 2018, Elsevier

    Prof. Francisco Marin

  186. Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray–Based Bone Assessment Techniques

    Article • Journal of Bone and Mineral Research, August 2018, Oxford University Press (OUP)

    Prof. Francisco Marin

  187. Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification

    Article • The FASEB Journal, August 2018, Federation of American Societies For Experimental Biology (FASEB)

    Dr Cristina Rodriguez, Prof. Francisco Marin

  188. Oral anticoagulation and comorbidities; too many details for clinical practice?

    Article • International Journal of Cardiology, August 2018, Elsevier

    Prof. Francisco Marin

  189. A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real-World” vs Clinical Trials

    Article • Mayo Clinic Proceedings, August 2018, Elsevier

    Prof. Francisco Marin

  190. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the Eu...

    Article • EP Europace, July 2018, Oxford University Press (OUP)

    Prof HECTOR BUENO, Prof. Francisco Marin

  191. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU

    Article • Revista Española de Cardiología (English Edition), July 2018, Elsevier

    Prof. Francisco Marin

  192. Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: Biomarker substudy results from a prospective study with rivaroxaban (X-TRA)

    Article • Annals of Medicine, June 2018, Taylor & Francis

    Kazuo Miyazawa, Prof. Francisco Marin

  193. Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)

    Article • Calcified Tissue International, June 2018, Springer Science + Business Media

    Prof. Francisco Marin , Tomaž Kocjan

  194. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), C...

    Article • EP Europace, June 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk, Prof. Francisco Marin

  195. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey

    Article • EP Europace, June 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk, Prof. Francisco Marin

  196. Invasive strategy and frailty in very elderly patients with acute coronary syndromes

    Article • EuroIntervention, June 2018, Europa Digital & Publishing

    Prof HECTOR BUENO, Prof. Francisco Marin

  197. Wnt Signaling Pathways Are Dysregulated in Rat Female Cerebellum Following Early Methyl Donor Deficiency

    Article • Molecular Neurobiology, May 2018, Springer Science + Business Media

    Prof. Francisco Marin

  198. Molecular modularity and asymmetry of the molluscan mantle revealed by a gene expression atlas

    Article • GigaScience, May 2018, Oxford University Press (OUP)

    Prof. Francisco Marin

  199. Teriparatide vs risedronate for osteoporosis – Authors' reply

    Article • The Lancet, May 2018, Elsevier

    Prof. Francisco Marin

  200. Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft‐Gault, Modification of Diet in Renal Disease‐4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronar...

    Article • Journal of the American Heart Association, April 2018, Wolters Kluwer Health

    María Asunción Esteve-Pastor, Prof. Francisco Marin

  201. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

    Article • European Journal of Clinical Investigation, April 2018, Wiley

    María Asunción Esteve-Pastor, Prof. Francisco Marin

  202. Optimizing Vitamin K Antagonist Treatment in Patients with Mechanical Heart Valve Prosthesis

    Article • Thrombosis and Haemostasis, April 2018, Thieme Publishing Group

    Prof. Francisco Marin

  203. Plant Lineage-Specific Amplification of Transcription Factor Binding Motifs by Miniature Inverted-Repeat Transposable Elements (MITEs)

    Article • Genome Biology and Evolution, April 2018, Oxford University Press (OUP)

    Prof. Francisco Marin

  204. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes

    Article • Journal of the American Medical Directors Association, April 2018, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  205. Design-validation of a hand exoskeleton using musculoskeletal modeling

    Article • Applied Ergonomics, April 2018, Elsevier

    Prof. Francisco Marin

  206. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project

    Article • Journal of General Internal Medicine, March 2018, Springer Science + Business Media

    Prof. Francisco Marin

  207. European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS)

    Article • EP Europace, March 2018, Oxford University Press (OUP)

    Prof. Francisco Marin

  208. Relation of quality of anticoagulation control with different management systems among patients with atrial fibrillation: Data from FANTASIIA Registry

    Article • European Journal of Clinical Investigation, March 2018, Wiley

    Prof. Francisco Marin

  209. Modeling and simulation of different and representative engineering problems using Network Simulation Method

    Article • PLOS One, March 2018, PLOS

    Prof. Francisco Marin

  210. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in ‘real-world’ atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients

    Article • International Journal of Cardiology, March 2018, Elsevier

    Prof. Francisco Marin

  211. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA 2 DS 2 -VASc and HAS-BLED

    Article • American Heart Journal, March 2018, Elsevier

    Prof. Francisco Marin

  212. Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality

    Article • Cardiology Journal, February 2018, VM Media SP. zo.o VM Group SK

    Prof. Francisco Marin

  213. Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

    Article • International Journal of Clinical Practice, February 2018, Wiley

    María Asunción Esteve-Pastor, Prof. Francisco Marin

  214. Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

    Article • Journal of Bone and Mineral Research, February 2018, Wiley

    Professor Salvatore MINISOLA, Prof. Francisco Marin

  215. The growth of interest for astronomical X-ray polarimetry

    Article • February 2018, MDPI AG

    Prof. Francisco Marin

  216. Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry

    Article • Thrombosis and Haemostasis, February 2018, Thieme Publishing Group

    Prof HECTOR BUENO, Prof. Francisco Marin

  217. Comments on the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases

    Article • Revista Española de Cardiología (English Edition), February 2018, Elsevier

    Prof. Francisco Marin

  218. Comments on the 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease

    Article • Revista Española de Cardiología (English Edition), February 2018, Elsevier

    Prof. Francisco Marin

  219. Imaging Correlations in Heterodyne Spectra for Quantum Displacement Sensing

    Article • Physical Review Letters, January 2018, American Physical Society (APS)

    Prof. Francisco Marin

  220. Polyphenolic Compounds, Antioxidant, and Cardioprotective Effects of Pomace Extracts from Fetească Neagră Cultivar

    Article • Oxidative Medicine and Cellular Longevity, January 2018, Hindawi Publishing Corporation

    Parvu Marcel, Prof. Francisco Marin

  221. A new twist on sea silk: the peculiar protein ultrastructure of fan shell and pearl oyster byssus

    Article • Soft Matter, January 2018, Royal Society of Chemistry

    Prof. Francisco Marin

  222. Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

    Article • Circulation Journal, January 2018, Japanese Circulation Society

    Prof. Francisco Marin

  223. Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease

    Article • Revista Española de Cardiología (English Edition), January 2018, Elsevier

    Prof. Francisco Marin

  224. Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy

    Article • Circulation Heart Failure, January 2018, Wolters Kluwer Health

    Prof. Francisco Marin

  225. Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry

    Article • Thrombosis and Haemostasis, January 2018, Thieme Publishing Group

    Prof. Francisco Marin

  226. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

    Article • Clinical Therapeutics, January 2018, Elsevier

    Prof. Francisco Marin

  227. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

    Article • The Lancet, January 2018, Elsevier

    Prof. Francisco Marin

  228. Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation

    Article • Circulation Journal, January 2018, Japanese Circulation Society

    Prof. Francisco Marin

  229. Comments on the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation

    Article • Revista Española de Cardiología (English Edition), December 2017, Elsevier

    Prof HECTOR BUENO, Prof. Francisco Marin

  230. Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation

    Article • The American Journal of Cardiology, December 2017, Elsevier

    Prof. Francisco Marin

  231. Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry

    Article • EP Europace, November 2017, Oxford University Press (OUP)

    Prof. Francisco Marin

  232. Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS)

    Article • EP Europace, November 2017, Oxford University Press (OUP)

    Prof. Francisco Marin

  233. Effects of a trail mountain race on neuromuscular performance and hydration status in trained runners

    Article • The Journal of Sports Medicine and Physical Fitness, November 2017, Edizioni Minerva Medica

    Prof. Francisco Marin

  234. Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

    Article • EP Europace, October 2017, Oxford University Press (OUP)

    Prof. Francisco Marin

  235. Estimation of the wrist joint center of rotation

    Article • Computer Methods in Biomechanics & Biomedical Engineering, October 2017, Taylor & Francis

    Prof. Francisco Marin

  236. Motion analysis of snare drum in relation with the musician’s expertise

    Article • Computer Methods in Biomechanics & Biomedical Engineering, October 2017, Taylor & Francis

    Prof. Francisco Marin

  237. Emotional concerns and coping strategies in Low Grade Glioma patients and reliability of their caregivers in reporting these concerns: Findings from a cross-sectional study

    Article • European Journal of Oncology Nursing, October 2017, Elsevier

    Prof. Francisco Marin

  238. Efficacy of non-vitamin-K antagonist oral anticoagulants for intracardiac thrombi resolution in nonvalvular atrial fibrillation

    Article • Drug Discovery Today, October 2017, Elsevier

    Prof. Francisco Marin

  239. Research update for articles published in EJCI in 2015

    Article • European Journal of Clinical Investigation, September 2017, Wiley

    Dr Federico Carbone, Dr. Ozra Tabatabaei-Malazy, Prof. Francisco Marin

  240. Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome

    Article • Oncotarget, September 2017, Impact Journals, LLC

    Prof. Francisco Marin

  241. Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

    Article • Scientific Reports, September 2017, Springer Science + Business Media

    Prof. Francisco Marin

  242. Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers

    Article • Annals of Medicine, September 2017, Taylor & Francis

    Prof. Francisco Marin

  243. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

    Article • EP Europace, September 2017, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Nika Kuridze, Prof. Francisco Marin

  244. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Worki...

    Article • EP Europace, August 2017, Oxford University Press (OUP)

    Prof. Francisco Marin

  245. Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, August 2017, SAGE Publications

    Prof. Francisco Marin

  246. Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation

    Article • Expert Opinion on Drug Safety, July 2017, Taylor & Francis

    María Asunción Esteve-Pastor, Prof. Francisco Marin

  247. Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad ...

    Article • EP Europace, July 2017, Oxford University Press (OUP)

    Prof. Francisco Marin

  248. The future of nutrition: Nutrigenomics and nutrigenetics in obesity and cardiovascular diseases

    Article • Critical Reviews in Food Science and Nutrition, July 2017, Taylor & Francis

    Prof. Francisco Marin

  249. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisio...

    Article • EP Europace, July 2017, Oxford University Press (OUP)

    Prof. Francisco Marin

  250. Percutaneous cryoablation of symptomatic venous malformations as a second-line therapeutic option: a five-year single institution experience

    Article • European Radiology, July 2017, Springer Science + Business Media

    Prof. Francisco Marin

  251. Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA 2 DS 2 ‐VASc Scores

    Article • Journal of the American Heart Association, July 2017, Wolters Kluwer Health

    María Asunción Esteve-Pastor, Prof. Francisco Marin

  252. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoameri...

    Article • EP Europace, June 2017, Oxford University Press (OUP)

    Professor Antonis S Manolis, Prof. Francisco Marin

  253. Hypertension and Cardiac Arrhythmias: Executive Summary of a Consensus Document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and...

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, May 2017, Oxford University Press (OUP)

    Professor Antonis S Manolis, Prof. Francisco Marin

  254. Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome

    Article • Critical Reviews in Food Science and Nutrition, May 2017, Taylor & Francis

    Prof. Francisco Marin

  255. Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry

    Article • European Journal of Cardiovascular Nursing, May 2017, SAGE Publications

    Prof. Francisco Marin

  256. Shell extracts of the edible mussel and oyster induce an enhancement of the catabolic pathway of human skin fibroblasts, in vitro

    Article • Cytotechnology, May 2017, Springer Science + Business Media

    Prof. Francisco Marin

  257. Analysis of the sEMG/force relationship using HD-sEMG technique and data fusion: A simulation study

    Article • Computers in Biology and Medicine, April 2017, Elsevier

    Prof. Francisco Marin

  258. Micronutrient supplementation in gastric bypass surgery: prospective study on inflammation and iron metabolism in premenopausal women

    Article • Nutrición Hospitalaria, March 2017, Sociedad Espanola de Nutricion Parenteral y Enteral (SENPE)

    Prof. Francisco Marin

  259. Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice

    Article • Expert Review of Cardiovascular Therapy, March 2017, Taylor & Francis

    Prof. Francisco Marin

  260. Applicability of the modified CHA 2 DS 2 -VASc score for stroke risk stratification in Caucasian atrial fibrillation patients

    Article • European Journal of Internal Medicine, March 2017, Elsevier

    Prof. Francisco Marin

  261. The Changing Landscape for Stroke Prevention in AF

    Article • Journal of the American College of Cardiology, February 2017, Elsevier

    Professor Catarina Fonseca, Dr Radoslaw Lenarczyk, M.D Ph.D Serge Timsit, Mr JOSE A. CALVO-MANZANO, Prof. Francisco Marin

  262. Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants

    Article • Revista Española de Cardiología (English Edition), February 2017, Elsevier

    Prof. Francisco Marin

  263. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

    Article • Scientific Reports, January 2017, Springer Science + Business Media

    Prof. Francisco Marin

  264. Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial

    Article • Journal of Bone and Mineral Research, January 2017, Wiley

    Dr. Kyriakos A Papavasiliou , DR. JORGE MALOUF-SIERRA, Prof. Francisco Marin

  265. Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation

    Article • Scientific Reports, January 2017, Springer Science + Business Media

    Prof. Francisco Marin

  266. Search for an Ultralight Scalar Dark Matter Candidate with the AURIGA Detector

    Article • Physical Review Letters, January 2017, American Physical Society (APS)

    Prof. Francisco Marin

  267. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endo...

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    Prof. Francisco Marin

  268. Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    Prof. Francisco Marin

  269. Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    Prof. Francisco Marin

  270. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    Prof. Francisco Marin

  271. Predicting bleeding risk after coronary surgery: Let’s focus on modifiable risk factors and simple, practical decision making

    Article • Thrombosis and Haemostasis, January 2017, Thieme Publishing Group

    Prof. Francisco Marin

  272. Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation

    Article • Revista Española de Cardiología (English Edition), January 2017, Elsevier

    Prof. Francisco Marin

  273. Deep conservation of bivalve nacre proteins highlighted by shell matrix proteomics of the Unionoida Elliptio complanata and Villosa lienosa

    Article • Journal of The Royal Society Interface, January 2017, Royal Society Publishing

    Prof. Francisco Marin

  274. Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles

    Article • Critical Reviews in Clinical Laboratory Sciences, December 2016, Taylor & Francis

    Prof. Francisco Marin

  275. Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation

    Article • Expert Opinion on Pharmacotherapy, December 2016, Taylor & Francis

    Prof. Francisco Marin

  276. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor

    Article • Advances in Therapy, December 2016, Springer Science + Business Media

    Prof. Francisco Marin

  277. Formation of localized sand patterns downstream from a vertical cylinder under steady flows: Experimental and theoretical study

    Article • November 2016, American Physical Society (APS)

    Prof. Francisco Marin

  278. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society ...

    Article • European Journal of Preventive Cardiology, November 2016, Oxford University Press (OUP)

    Prof. Francisco Marin

  279. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society ...

    Article • EP Europace, November 2016, European Society of Cardiology

    Prof. Francisco Marin

  280. Teriparatide and Risedronate After Hip Fracture

    Article • Journal of Bone and Joint Surgery, November 2016, The Journal of Bone and Joint Surgery, Inc.

    Professor Søren Overgaard, DR. JORGE MALOUF-SIERRA, José R. Caeiro, Dr. Kyriakos A Papavasiliou , Eric LESPESSAILLES, Prof. Francisco Marin

  281. Is oral anticoagulation needed in patients with atrial fibrillation and stent implantation at low–moderate risk of stroke?

    Article • European Journal of Internal Medicine, November 2016, Elsevier

    Prof. Francisco Marin

  282. Oral anticoagulation in octogenarians with atrial fibrillation

    Article • International Journal of Cardiology, November 2016, Elsevier

    Prof. Francisco Marin

  283. Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction

    Article • European Journal of Internal Medicine, November 2016, Elsevier

    Prof. Francisco Marin

  284. Organic matrices in metazoan calcium carbonate skeletons: Composition, functions, evolution

    Article • Journal of Structural Biology, November 2016, Elsevier

    Prof. Francisco Marin

  285. Expression patterns of Irx genes in the developing chick inner ear

    Article • Brain Structure and Function, October 2016, Springer Science + Business Media

    Professor Luis Puelles, Prof. Francisco Marin

  286. The wearable cardioverter-defibrillator: current technology and evolving indications

    Article • EP Europace, October 2016, European Society of Cardiology

    Prof. Francisco Marin

  287. Structural Heart Disease in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Prevalence and Clinical Profile in a Spanish Sample

    Article • Revista Española de Cardiología (English Edition), October 2016, Elsevier

    Prof. Francisco Marin

  288. Sport, health and sudden death

    Article • International Journal of Cardiology, October 2016, Elsevier

    Prof. Francisco Marin

  289. Classification of physical activities based on body-segments coordination

    Article • Computers in Biology and Medicine, September 2016, Elsevier

    Prof. Francisco Marin

  290. Extraction of the Brachialis muscle activity using HD-sEMG technique and canonical correlation analysis

    Article • August 2016, Institute of Electrical & Electronics Engineers (IEEE)

    Prof. Francisco Marin

  291. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)

    Article • American Heart Journal, August 2016, Elsevier

    Prof. Francisco Marin

  292. The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion

    Article • International Journal of Cardiology, August 2016, Elsevier

    Prof. Francisco Marin

  293. Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy

    Article • Current Medicinal Chemistry, July 2016, Bentham Science Publishers

    Assistant Professor Tatjana S Potpara, Prof. Francisco Marin

  294. Strategies for prediction and early detection of atrial fibrillation: present and future

    Article • EP Europace, July 2016, European Society of Cardiology

    Prof. Francisco Marin

  295. Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold

    Article • Platelets, June 2016, Taylor & Francis

    Prof. Francisco Marin

  296. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome

    Article • Clinical Cardiology, June 2016, Wiley

    Prof. Francisco Marin

  297. On the Way to a Better Use of Anticoagulants in Nonvalvular Atrial Fibrillation. Proposed Amendment to the Therapeutic Positioning Report UT/V4/23122013

    Article • Revista Española de Cardiología (English Edition), June 2016, Elsevier

    Prof. Francisco Marin

  298. Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System

    Article • The Journal of Maternal-Fetal & Neonatal Medicine, May 2016, Taylor & Francis

    Prof. Francisco Marin

  299. Denoising of HD-sEMG signals using canonical correlation analysis

    Article • Medical & Biological Engineering & Computing, May 2016, Springer Science + Business Media

    Prof. Francisco Marin

  300. The Shell of the Invasive Bivalve Species Dreissena polymorpha: Biochemical, Elemental and Textural Investigations

    Article • PLOS One, May 2016, PLOS

    Prof. Francisco Marin

  301. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer‐based calculation of CHADS2 and CHA2DS2‐VASc scores

    Article • Internal Medicine Journal, May 2016, Wiley

    Prof. Francisco Marin

  302. miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients

    Article • Annals of Translational Medicine, May 2016, AME Publishing Company

    Prof. Francisco Marin

  303. Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies

    Article • Molecular Cancer Therapeutics, May 2016, American Association for Cancer Research (AACR)

    Prof. Francisco Marin

  304. Evidence From Pacing in Obstructive Hypertrophic Cardiomyopathy

    Article • Revista Española de Cardiología (English Edition), May 2016, Elsevier

    Prof. Francisco Marin

  305. Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

    Article • Calcified Tissue International, April 2016, Springer Science + Business Media

    Tomaž Kocjan, Prof. Francisco Marin

  306. Testing Quantum Gravity Induced Nonlocality via Optomechanical Quantum Oscillators

    Article • Physical Review Letters, April 2016, American Physical Society (APS)

    Prof. Francisco Marin

  307. Dynamical Two-Mode Squeezing of Thermal Fluctuations in a Cavity Optomechanical System

    Article • Physical Review Letters, March 2016, American Physical Society (APS)

    Prof. Francisco Marin

  308. Water-Soluble Compounds from Lentinula edodes Influencing the HMG-CoA Reductase Activity and the Expression of Genes Involved in the Cholesterol Metabolism

    Article • Journal of Agricultural and Food Chemistry, March 2016, American Chemical Society (ACS)

    Prof. Francisco Marin

  309. A minimal molecular toolkit for mineral deposition? Biochemistry and proteomics of the test matrix of adult specimens of the sea urchin Paracentrotus lividus

    Article • Journal of Proteomics, March 2016, Elsevier

    Prof. Francisco Marin

  310. New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

    Article • Molecules, February 2016, MDPI AG

    Prof. Francisco Marin

  311. Plasma Cholesterol-Lowering Activity of Lard Functionalized with Mushroom Extracts Is Independent of Niemann–Pick C1-like 1 Protein and ABC Sterol Transporter Gene Expression in Hypercholesterolemic Mice

    Article • Journal of Agricultural and Food Chemistry, February 2016, American Chemical Society (ACS)

    Prof. Francisco Marin

  312. Teriparatide for osteoporosis: importance of the full course

    Article • Osteoporosis International, February 2016, Springer Science + Business Media

    Prof. Francisco Marin

  313. Prospects for Increasing Sugarcane and Bioethanol Production on Existing Crop Area in Brazil

    Article • BioScience, February 2016, Oxford University Press (OUP)

    Prof. Francisco Marin

  314. Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion

    Article • Circulation Journal, January 2016, Japanese Circulation Society

    Prof. Francisco Marin

  315. Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

    Article • Circulation Journal, January 2016, Japanese Circulation Society

    María Asunción Esteve-Pastor, Prof. Francisco Marin

  316. Assessment of bleeding risk in acute ill medical patients. An essential part of venous thromboembolism prevention

    Article • Thrombosis and Haemostasis, January 2016, Thieme Publishing Group

    Prof. Francisco Marin

  317. Current Antiarrhythmic Therapy for Nonvalvular Atrial Fibrillation in Spain. Data From the FANTASIIA Registry

    Article • Revista Española de Cardiología (English Edition), January 2016, Elsevier

    Prof. Francisco Marin

  318. Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy

    Article • European Journal of Clinical Investigation, December 2015, Wiley

    Prof. Francisco Marin

  319. The SAMe-TT2R2score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation

    Article • Expert Review of Cardiovascular Therapy, December 2015, Taylor & Francis

    Prof. Francisco Marin

  320. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2015, New England Journal of Medicine (NEJM/MMS)

    Professor Vladimir V Rafalskiy, Professor john j mcmurray, Prof. Francisco Marin , Ponnusamy Saravanan

  321. Nanoscale assembly processes revealed in the nacroprismatic transition zone of Pinna nobilis mollusc shells

    Article • Nature Communications, December 2015, Springer Science + Business Media

    Prof. Francisco Marin

  322. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery

    Article • EP Europace, November 2015, European Society of Cardiology

    Prof. Francisco Marin

  323. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective ‘Real-world’ Inception Cohort Study

    Article • The American Journal of Medicine, November 2015, Elsevier

    Prof. Francisco Marin

  324. On the benefits of using HD-sEMG technique for estimating muscle force

    Article • Computer Methods in Biomechanics & Biomedical Engineering, September 2015, Taylor & Francis

    Prof. Francisco Marin

  325. Clinical development of rivaroxaban: emerging new clinical evidences?

    Article • Future Cardiology, September 2015, Future Medicine

    Prof. Francisco Marin

  326. Trastornos del desarrollo en niños y adolescentes de la región de Los Ríos, Valdivia, Chile, 2006-2008

    Article • Revista chilena de pediatría, September 2015, Sociedad Chilena de Pediatria

    Prof. Francisco Marin

  327. Friction coefficient analysis during high-heeled gait

    Article • Computer Methods in Biomechanics & Biomedical Engineering, August 2015, Taylor & Francis

    Prof. Francisco Marin

  328. 3D location deduced by inertial measurement units: a challenging problem

    Article • Computer Methods in Biomechanics & Biomedical Engineering, August 2015, Taylor & Francis

    Prof. Francisco Marin

  329. Proposition, identification, and experimental evaluation of an inverse dynamic neuromusculoskeletal model for the human finger

    Article • Computers in Biology and Medicine, August 2015, Elsevier

    Prof. Francisco Marin

  330. Motion capture for functional analysis of new biomaterials in a small animal model

    Article • Computer Methods in Biomechanics & Biomedical Engineering, July 2015, Taylor & Francis

    Prof. Francisco Marin

  331. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation

    Article • Journal of Cardiovascular Pharmacology and Therapeutics, July 2015, SAGE Publications

    Prof. Francisco Marin

  332. sST2 levels are associated with all‐cause mortality in anticoagulated patients with atrial fibrillation

    Article • European Journal of Clinical Investigation, July 2015, Wiley

    Prof. Francisco Marin

  333. Trichoderma saturnisporum, a new biological control agent

    Article • Journal of the Science of Food and Agriculture, July 2015, Wiley

    Prof. Francisco Marin

  334. Novel biomarkers in cardiology: MicroRNAs in atrial fibrillation

    Article • Archivos de Cardiología de México, July 2015, Publicidad Permanyer, SLU

    Prof. Francisco Marin

  335. The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists

    Article • Thrombosis and Haemostasis, July 2015, Thieme Publishing Group

    Prof. Francisco Marin

  336. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Soc...

    Article • EP Europace, June 2015, European Society of Cardiology

    Prof. Francisco Marin

  337. Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Socie...

    Article • EP Europace, June 2015, European Society of Cardiology

    Prof. Francisco Marin

  338. Probing deformed commutators with macroscopic harmonic oscillators

    Article • Nature Communications, June 2015, Springer Science + Business Media

    Prof. Francisco Marin

  339. De novo mutations in PLXND1 and REV3L cause Möbius syndrome

    Article • Nature Communications, June 2015, Springer Science + Business Media

    Prof. Francisco Marin

  340. Simulating tropical forage growth and biomass accumulation: an overview of model development and application

    Article • Grass and Forage Science, June 2015, Wiley

    Prof. Francisco Marin

  341. Importance of Sudden Cardiac Death Risk Stratification in Hypertrophic Cardiomyopathy

    Article • Revista Española de Cardiología (English Edition), June 2015, Elsevier

    Prof. Francisco Marin

  342. Satisfaction With Medical Care in Patients With Atrial Fibrillation Treated With Vitamin K Antagonists Versus New Oral Anticoagulants

    Article • Revista Española de Cardiología (English Edition), June 2015, Elsevier

    Prof. Francisco Marin

  343. Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation

    Article • Revista Española de Cardiología (English Edition), June 2015, Elsevier

    Prof. Francisco Marin

  344. Quality of Anticoagulation With Vitamin K Antagonists

    Article • Clinical Cardiology, May 2015, Wiley

    Prof. Francisco Marin

  345. Modulation of cholesterol-related gene expression by ergosterol and ergosterol-enriched extracts obtained from Agaricus bisporus

    Article • European Journal of Nutrition, May 2015, Springer Science + Business Media

    Prof. Francisco Marin

  346. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    Article • American Heart Journal, May 2015, Elsevier

    Professor Vladimir V Rafalskiy, Professor john j mcmurray, Professor Tzung-Dau Wang, Professor Rayaz Ahmed Malik, Prof. Francisco Marin , Ponnusamy Saravanan

  347. CALU polymorphism A29809G affects calumenin availability involving vascular calcification

    Article • Journal of Molecular and Cellular Cardiology, May 2015, Elsevier

    Jose Martinez Gonzalez, Dr Cristina Rodriguez, Prof. Francisco Marin

  348. Ultrastructure of the Interlamellar Membranes of the Nacre of the Bivalve Pteria hirundo, Determined by Immunolabelling

    Article • PLOS One, April 2015, PLOS

    Prof. Francisco Marin

  349. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry p...

    Article • American Heart Journal, April 2015, Elsevier

    Prof. Francisco Marin

  350. Spine and test skeletal matrices of the Mediterranean sea urchinArbacia lixula- a comparative characterization of their sugar signature

    Article • European Journal of Biochemistry, March 2015, Wiley

    Prof. Francisco Marin

  351. Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome

    Article • European Journal of Clinical Investigation, March 2015, Wiley

    Prof. Francisco Marin

  352. Update on Ischemic Heart Disease and Intensive Cardiac Care

    Article • Revista Española de Cardiología (English Edition), March 2015, Elsevier

    Prof. Francisco Marin

  353. The test skeletal matrix of the black sea urchin Arbacia lixula

    Article • Comparative Biochemistry and Physiology Part D Genomics and Proteomics, March 2015, Elsevier

    Prof. Francisco Marin

  354. Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis

    Article • Osteoporosis International, February 2015, Springer Science + Business Media

    Prof. Francisco Marin

  355. Dysphagia Diagnosed by Fiberoptic Endoscopy Is Common and Transient in Critical Illness Polyneuropathy

    Article • Critical Care Medicine, February 2015, Wolters Kluwer Health

    Prof. Francisco Marin

  356. Lactational exposure to low levels of the six indicator non-dioxin-like polychlorinated biphenyls induces DNA damage and repression of neuronal activity, in juvenile male mice

    Article • Toxicology, February 2015, Elsevier

    Prof. Francisco Marin

  357. TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy

    Article • European Journal of Clinical Investigation, January 2015, Wiley

    Prof. Francisco Marin

  358. Remarkable Proanthocyanidin Adsorption Properties of Monastrell Pomace Cell Wall Material Highlight Its Potential Use as an Alternative Fining Agent in Red Wine Production

    Article • Journal of Agricultural and Food Chemistry, January 2015, American Chemical Society (ACS)

    Prof. Francisco Marin

  359. Involvement of the −420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy

    Article • Journal of Internal Medicine, January 2015, Wiley

    Prof. Francisco Marin

  360. Effect of Selenium-Enriched Agaricus bisporus (Higher Basidiomycetes) Extracts, Obtained by Pressurized Water Extraction, on the Expression of Cholesterol Homeostasis Related Genes by Low-Density Array

    Article • International Journal of Medicinal Mushrooms, January 2015, Begell House

    Dr Arantxa Rodriguez-Casado, Prof. Francisco Marin

  361. The search for optimal anticoagulation therapy in ACS: The gap between clinical trials and current clinical guidelines

    Article • Thrombosis and Haemostasis, January 2015, Thieme Publishing Group

    Prof. Francisco Marin

  362. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists

    Article • Thrombosis and Haemostasis, January 2015, Thieme Publishing Group

    Prof. Francisco Marin

  363. Comments on the 2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism

    Article • Revista Española de Cardiología (English Edition), January 2015, Elsevier

    Prof. Francisco Marin

  364. Oral Anticoagulation in Japanese Patients With Atrial Fibrillation

    Article • Circulation Journal, January 2015, Japanese Circulation Society

    Prof. Francisco Marin

  365. Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

    Article • Journal of Atherosclerosis and Thrombosis, January 2015, Japan Atherosclerosis Society

    Prof. Francisco Marin

  366. Lone Atrial Fibrillation- A Diagnosis of Exclusion

    Article • Current Pharmaceutical Design, December 2014, Bentham Science Publishers

    Prof. Francisco Marin

  367. GDF-15 and risk stratification in atrial fibrillation

    Article • Nature Reviews Cardiology, November 2014, Springer Science + Business Media

    Prof. Francisco Marin

  368. Red Cell Distribution Width and Coronary Artery Disease. Response

    Article • Revista Española de Cardiología (English Edition), November 2014, Elsevier

    Prof. Francisco Marin

  369. SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation

    Article • The American Journal of Medicine, November 2014, Elsevier

    Prof. Francisco Marin

  370. Reactivity of pure and commercial grape skin tannins with cell wall material

    Article • European Food Research and Technology, October 2014, Springer Science + Business Media

    Prof. Francisco Marin

  371. Red Cell Distribution Width and Additive Risk Prediction for Major Bleeding in Non–ST-segment Elevation Acute Coronary Syndrome

    Article • Revista Española de Cardiología (English Edition), October 2014, Elsevier

    Prof. Francisco Marin

  372. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group ...

    Article • European Heart Journal, August 2014, European Society of Cardiology

    Prof HECTOR BUENO, Prof. Francisco Marin

  373. Dynamic Prognostic Stratification in ST–elevation Myocardial Infarction. Response

    Article • Revista Española de Cardiología (English Edition), July 2014, Elsevier

    Prof. Francisco Marin

  374. Methods of kidney function assessment in non-valvular atrial fibrillation in the era of new oral anticoagulants

    Article • European Journal of Internal Medicine, July 2014, Elsevier

    Prof. Francisco Marin

  375. Recanalization and Mortality Rates of Thrombectomy With Stent-Retrievers in Octogenarian Patients with Acute Ischemic Stroke

    Article • CardioVascular and Interventional Radiology, June 2014, Springer Science + Business Media

    Prof. Francisco Marin

  376. C0487: NT-proBNP Provided Complementary Prognostic Information to an Established Clinical Risk Score (CHA2DS2-VASc) for the Prediction of Stroke/Systemic Embolism

    Article • Thrombosis Research, May 2014, Elsevier

    Prof. Francisco Marin

  377. Use of Antithrombotic Therapy in Patients With Atrial Fibrillation in Primary Care. Importance of INR Control

    Article • Revista Española de Cardiología (English Edition), May 2014, Elsevier

    Prof. Francisco Marin

  378. Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin

    Article • British Journal of Haematology, April 2014, Wiley

    Prof. Francisco Marin

  379. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy

    Article • QJM, March 2014, Oxford University Press (OUP)

    Prof. Francisco Marin

  380. Usefulness of N-Terminal Pro–B-Type Natriuretic Peptide Levels for Stroke Risk Prediction in Anticoagulated Patients With Atrial Fibrillation

    Article • Stroke, March 2014, Wolters Kluwer Health

    Prof. Francisco Marin

  381. Update on Ischemic Heart Disease and Critical Care Cardiology

    Article • Revista Española de Cardiología (English Edition), February 2014, Elsevier

    Prof. Francisco Marin

  382. Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation

    Article • Thrombosis and Haemostasis, January 2014, Thieme Publishing Group

    Prof. Francisco Marin

  383. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting

    Article • Thrombosis and Haemostasis, January 2014, Thieme Publishing Group

    Prof. Francisco Marin , Professor Deepak L Bhatt

  384. Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients

    Article • International Journal of Clinical Practice, December 2013, Wiley

    Prof. Francisco Marin

  385. Biomarkers in atrial fibrillation: an overview

    Article • International Journal of Clinical Practice, December 2013, Hindawi Publishing Corporation

    Prof. Francisco Marin

  386. The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial Fibrillation

    Article • Journal of the American College of Cardiology, December 2013, Elsevier

    Prof. Francisco Marin

  387. β-Trace Protein and Prognosis in Patients With Atrial Fibrillation Receiving Anticoagulation Treatment

    Article • CHEST Journal, November 2013, Elsevier

    Prof. Francisco Marin

  388. Manifestaciones neurológicas de los mixomas cardiacos. Experiencia en un centro de referencia

    Article • Neurología, November 2013, Elsevier

    Prof. Francisco Marin

  389. High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery

    Article • European Journal of Cardio-Thoracic Surgery, October 2013, Oxford University Press (OUP)

    Prof. Francisco Marin

  390. Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?

    Article • Internal and Emergency Medicine, October 2013, Springer Science + Business Media

    Prof. Francisco Marin

  391. Role of microRNAs in cardiac remodelling: New insights and future perspectives

    Article • International Journal of Cardiology, September 2013, Elsevier

    Prof. Francisco Marin

  392. N-terminal Pro-brain Natriuretic Peptide and High-sensitivity Troponin in the Evaluation of Acute Chest Pain of Uncertain Etiology. A PITAGORAS Substudy

    Article • Revista Española de Cardiología (English Edition), July 2013, Elsevier

    Prof. Francisco Marin

  393. The complex role of bone turnover biomarkers in cardiovascular diseases

    Article • European Journal of Heart Failure, June 2013, Wiley

    Prof. Francisco Marin

  394. Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches

    Article • Annals of Medicine, May 2013, Taylor & Francis

    Prof. Francisco Marin

  395. Letter by Marín et al Regarding Article, “Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study”

    Article • Circulation, April 2013, Wolters Kluwer Health

    Prof. Francisco Marin

  396. Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)

    Article • The American Journal of Cardiology, April 2013, Elsevier

    Prof. Francisco Marin

  397. Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes

    Article • Atherosclerosis, April 2013, Elsevier

    Prof. Francisco Marin

  398. Interleukin-6 and High-sensitivity C-reactive Protein for the Prediction of Outcomes in Non-ST-segment Elevation Acute Coronary Syndromes

    Article • Revista Española de Cardiología (English Edition), March 2013, Elsevier

    Prof. Francisco Marin

  399. Eco-Doppler de ejercicio en pacientes con miocardiopatía hipertrófica. Factores determinantes de la limitación funcional

    Article • Revista Española de Cardiología, February 2013, Elsevier

    Prof. Francisco Marin

  400.  -Trace Protein: From GFR Marker to Cardiovascular Risk Predictor

    Article • Clinical Journal of the American Society of Nephrology, January 2013, American Society of Nephrology

    Professor James Januzzi, Prof. Francisco Marin

  401. Beta-Trace Protein and Cystatin C as Predictors of Major Bleeding in Non-ST-Segment Elevation Acute Coronary Syndrome

    Article • Circulation Journal, January 2013, Japanese Circulation Society

    Prof. Francisco Marin

  402. Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy

    Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

    Prof. Francisco Marin

  403. Tratamiento antitrombótico y tipo de stent en pacientes con fibrilación auricular a los que se practica una intervención coronaria percutánea

    Article • Revista Española de Cardiología, January 2013, Elsevier

    Prof. Francisco Marin

  404. Antithrombotic therapy and bleeding risk in atrial fibrillation. Fewer unanswered questions

    Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

    Prof. Francisco Marin

  405. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

    Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

    Prof. Francisco Marin

  406. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

    Article • Thrombosis and Haemostasis, January 2013, Thieme Publishing Group

    Prof. Francisco Marin

  407. Oral anticoagulation for heart failure in sinus rhythm: from evidence to clinical recommendations, or not?

    Article • European Journal of Heart Failure, January 2013, Wiley

    Prof. Francisco Marin

  408. Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

    Article • CHEST Journal, January 2013, Elsevier

    Prof. Francisco Marin

  409. The prognostic role of the adiponectin levels in atrial fibrillation

    Article • European Journal of Clinical Investigation, December 2012, Wiley

    Prof. Francisco Marin

  410. Atherosclerosis and thromboembolic risk in atrial fibrillation: Focus on peripheral vascular disease

    Article • Annals of Medicine, December 2012, Taylor & Francis

    Prof. Francisco Marin

  411. Prior aspirin therapy and cardiovascular implantable electronic device infections

    Article • EP Europace, November 2012, European Society of Cardiology

    Prof. Francisco Marin

  412. High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a reply to a rebuttal

    Article • Journal of Thrombosis and Haemostasis, November 2012, Elsevier

    Prof. Francisco Marin

  413. Usefulness of β-Trace Protein and Cystatin C for the Prediction of Mortality in Non ST Segment Elevation Acute Coronary Syndromes

    Article • The American Journal of Cardiology, November 2012, Elsevier

    Prof. Francisco Marin

  414. Comparative Determination and Monitoring of Biomarkers of Necrosis and Myocardial Remodeling between Radiofrequency Ablation and Cryoablation

    Article • Pacing and Clinical Electrophysiology, October 2012, Wiley

    Prof. Francisco Marin

  415. Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

    Article • European Journal of Clinical Investigation, October 2012, Wiley

    Prof. Francisco Marin

  416. Pre and Post-Operative Treatments for Prevention of Atrial Fibrillation after Cardiac Surgery

    Article • Mini-Reviews in Medicinal Chemistry, October 2012, Bentham Science Publishers

    Prof. Francisco Marin

  417. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

    Article • Age and Ageing, September 2012, Oxford University Press (OUP)

    Prof. Francisco Marin

  418. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage

    Article • American Heart Journal, August 2012, Elsevier

    Prof. Francisco Marin

  419. High sensitivity cardiac troponin T and interleukin‐6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation

    Article • Journal of Thrombosis and Haemostasis, August 2012, Elsevier

    Prof. Francisco Marin

  420. Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score?

    Article • Circulation Cardiovascular Interventions, August 2012, Wolters Kluwer Health

    Prof. Francisco Marin

  421. Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients

    Article • Journal of Internal Medicine, July 2012, Wiley

    Prof. Francisco Marin

  422. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis

    Article • European Journal of Heart Failure, July 2012, Wiley

    Professor john j mcmurray, Prof. Francisco Marin

  423. Predictive Value of the CHA2DS2-VASc Score in Atrial Fibrillation Patients at High Risk for Stroke Despite Oral Anticoagulation

    Article • Revista Española de Cardiología (English Edition), July 2012, Elsevier

    Prof. Francisco Marin

  424. Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?

    Article • Expert Opinion on Pharmacotherapy, May 2012, Informa Healthcare

    Prof. Francisco Marin

  425. Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

    Article • Circulation Arrhythmia and Electrophysiology, April 2012, Wolters Kluwer Health

    Prof. Francisco Marin

  426. Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy

    Article • European Journal of Internal Medicine, March 2012, Elsevier

    Prof. Francisco Marin

  427. Influence of CYP2C19 Polymorphisms in Platelet Reactivity and Prognosis in an Unselected Population of Non ST Elevation Acute Coronary Syndrome

    Article • Revista Española de Cardiología (English Edition), March 2012, Elsevier

    Prof. Francisco Marin

  428. Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders

    Article • Current Pharmaceutical Design, February 2012, Bentham Science Publishers

    Prof. Francisco Marin

  429. CardioPulse Articles

    Article • European Heart Journal, January 2012, European Society of Cardiology

    Prof. Francisco Marin

  430. New Perspectives in Antiplatelet Therapy

    Article • Current Medicinal Chemistry, January 2012, Bentham Science Publishers

    Prof. Francisco Marin

  431. Edoxaban in Japanese Patients With Nonvalvular Atrial Fibrillation

    Article • Circulation Journal, January 2012, Japanese Circulation Society

    Prof. Francisco Marin

  432. High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS

    Article • The Scientific World JOURNAL, January 2012, Hindawi Publishing Corporation

    Prof. Francisco Marin

  433. Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting

    Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

    Prof. Francisco Marin

  434. New Evidence, New Controversies: a Critical Review of the European Society of Cardiology 2010 Clinical Practice Guidelines on Atrial Fibrillation

    Article • Revista Española de Cardiología (English Edition), January 2012, Elsevier

    Prof. Francisco Marin

  435. Oral anticoagulation in chronic kidney disease: A huge challenge

    Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

    Prof. Francisco Marin

  436. Primary Prevention With Aspirin in Type 2 Diabetic Patients

    Article • Circulation Journal, January 2012, Japanese Circulation Society

    Prof. Francisco Marin

  437. Pro: “Antidote for new anticoagulants” – Specific target of inhibition requires a specific target for neutralisation

    Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

    Prof. Francisco Marin

  438. Stroke and Thromboembolism in Atrial Fibrillation

    Article • Circulation Journal, January 2012, Japanese Circulation Society

    Prof. Francisco Marin

  439. The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage

    Article • Journal of the American College of Cardiology, January 2012, Elsevier

    Prof. Francisco Marin

  440. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm

    Article • Thrombosis and Haemostasis, January 2012, Thieme Publishing Group

    Prof. Francisco Marin

  441. Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?

    Article • Thrombosis Research, December 2011, Elsevier

    Prof. Francisco Marin

  442. A New Landscape for Stroke Prevention in Atrial Fibrillation

    Article • Stroke, November 2011, Wolters Kluwer Health

    Prof. Francisco Marin

  443. Prevención de complicaciones hemorrágicas en el síndrome coronario agudo

    Article • Medicina Clínica, November 2011, Elsevier

    Prof. Francisco Marin

  444. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study

    Article • Thrombosis Research, October 2011, Elsevier

    Prof. Francisco Marin

  445. The Improved but Unfinished Business of Stroke Risk Stratification in Atrial Fibrillation

    Article • Revista Española de Cardiología (English Edition), August 2011, Elsevier

    Prof. Francisco Marin

  446. Prognostic Value of Mean Platelet Volume in Patients With Non-ST-Elevation Acute Coronary Syndrome

    Article • Angiology, July 2011, SAGE Publications

    Prof. Francisco Marin

  447. An Insight of Novel Pharmacological Therapies in Hypertrophic Cardiomyopathy

    Article • Medicinal Chemistry, July 2011, Bentham Science Publishers

    Prof. Francisco Marin

  448. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity

    Article • Basic Research in Cardiology, June 2011, Springer Science + Business Media

    Prof. Francisco Marin

  449. Interactions Between Clopidogrel and Proton Pump Inhibitors: A Review of Evidence

    Article • Current Medicinal Chemistry, June 2011, Bentham Science Publishers

    Prof. Francisco Marin

  450. Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients

    Article • Journal of the American College of Cardiology, June 2011, Elsevier

    Prof. Francisco Marin

  451. An Evaluation of the CHADS2 Stroke Risk Score in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Revascularization

    Article • CHEST Journal, June 2011, Elsevier

    Prof. Francisco Marin

  452. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

    Article • EP Europace, April 2011, European Society of Cardiology

    Prof. Francisco Marin

  453. Impact of polymorphisms in the renin–angiotensin–aldosterone system on hypertrophic cardiomyopathy

    Article • Journal of the Renin-Angiotensin-Aldosterone System, April 2011, SAGE Publications

    Prof. Francisco Marin

  454. Peri-operative management of ophthalmic patients taking antithrombotic therapy

    Article • International Journal of Clinical Practice, February 2011, Hindawi Publishing Corporation

    Prof. Francisco Marin

  455. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Similarities and dissimilarities between North America and Europe

    Article • Thrombosis and Haemostasis, January 2011, Thieme Publishing Group

    Prof. Francisco Marin

  456. Bleeding risk assessment and management in atrial fibrillation patients

    Article • Thrombosis and Haemostasis, January 2011, Thieme Publishing Group

    Prof. Francisco Marin

  457. Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2011, De Gruyter

    Prof. Francisco Marin

  458. Serum Levels of High-Sensitivity Troponin T: A Novel Marker for Cardiac Remodeling in Hypertrophic Cardiomyopathy

    Article • Journal of Cardiac Failure, December 2010, Elsevier

    Prof. Francisco Marin

  459. Thrombogenesis in lone atrial fibrillation: a role for soluble P-selectin?

    Article • EP Europace, October 2010, European Society of Cardiology

    Prof. Francisco Marin

  460. The prognostic value of biomarkers after a premature myocardial infarction

    Article • International Journal of Cardiology, September 2010, Elsevier

    Prof. Francisco Marin

  461. Rhythm control agents and adverse events in patients with atrial fibrillation

    Article • International Journal of Clinical Practice, August 2010, Hindawi Publishing Corporation

    Prof. Francisco Marin

  462. Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

    Article • Annals of Medicine, August 2010, Taylor & Francis

    Prof. Francisco Marin

  463. CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

    Article • Annals of Medicine, August 2010, Taylor & Francis

    Prof. Francisco Marin

  464. Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy

    Article • Thrombosis Research, July 2010, Elsevier

    Prof. Francisco Marin

  465. Enzyme Replacement Therapy in Fabry Disease: Influence on Cardiac Manifestations

    Article • Current Medicinal Chemistry, June 2010, Bentham Science Publishers

    Prof. Francisco Marin

  466. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed b...

    Article • European Heart Journal, May 2010, European Society of Cardiology

    Prof. Francisco Marin

  467. Hypouricemic effect of statins: Another pleiotropic benefit?

    Article • Journal of Thoracic and Cardiovascular Surgery, May 2010, Elsevier

    Prof. Francisco Marin

  468. Effects of atorvastatin 80 mg daily on indices of matrix remodelling in ‘high-risk’ patients with ischemic heart disease

    Article • International Journal of Cardiology, February 2010, Elsevier

    Prof. Francisco Marin

  469. The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?

    Article • Heart, February 2010, BMJ

    Prof. Francisco Marin

  470. Glycoprotein inhibitors in patients on chronic anticoagulation: Safe enough or too much risk?

    Article • Thrombosis and Haemostasis, January 2010, Thieme Publishing Group

    Prof. Francisco Marin

  471. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

    Article • Thrombosis and Haemostasis, January 2010, Thieme Publishing Group

    Prof. Francisco Marin

  472. Synergism between factor XII –4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

    Article • Thrombosis and Haemostasis, January 2010, Thieme Publishing Group

    Prof. Francisco Marin

  473. Miocardiopatía hipertrófica. Estudio del gen de la troponina T en 127 familias españolas

    Article • Revista Española de Cardiología, December 2009, Elsevier

    Prof. Francisco Marin

  474. ¿Existe un efecto beneficioso a largo plazo con el tratamiento con marcapasos de la miocardiopatía hipertrófica obstructiva severa?

    Article • Revista Española de Cardiología, November 2009, Elsevier

    Prof. Francisco Marin

  475. Biomarcadores en la estratificación del riesgo del síndrome coronario agudo sin elevación del segmento ST: ¿hay algo más después de la troponina?

    Article • Medicina Clínica, October 2009, Elsevier

    Prof. Francisco Marin

  476. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling

    Article • International Journal of Clinical Practice, October 2009, Hindawi Publishing Corporation

    Prof. Francisco Marin

  477. Pharmacogenetics in Cardiovascular Antithrombotic Therapy

    Article • Journal of the American College of Cardiology, September 2009, Elsevier

    Prof. Francisco Marin

  478. Premature coronary artery disease in young (age < 45) subjects: Interactions of lipid profile, thrombophilic and haemostatic markers

    Article • International Journal of Cardiology, August 2009, Elsevier

    Prof. Francisco Marin

  479. Implications of Pharmacogenetics for Oral Anticoagulants Metabolism

    Article • Current Drug Metabolism, July 2009, Bentham Science Publishers

    Prof. Francisco Marin

  480. Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence

    Article • EP Europace, June 2009, European Society of Cardiology

    Prof. Francisco Marin

  481. “Antithrombotic therapy after coronary stenting in patients with indication for oral anticoagulation”

    Article • International Journal of Cardiology, May 2009, Elsevier

    Prof. Francisco Marin

  482. Does the Holy Grail escape us again?

    Article • European Heart Journal, April 2009, European Society of Cardiology

    Prof. Francisco Marin

  483. Impact of Chronic Kidney Disease on Major Bleeding Complications and Mortality in Patients With Indication for Oral Anticoagulation Undergoing Coronary Stenting

    Article • CHEST Journal, April 2009, Elsevier

    Prof. Francisco Marin

  484. Dispersión del intervalo QT y miocardio viable

    Article • Revista Española de Cardiología, April 2009, Elsevier

    Prof. Francisco Marin

  485. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation

    Article • International Journal of Cardiology, February 2009, Elsevier

    Prof. Francisco Marin

  486. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis

    Article • Thrombosis and Haemostasis, January 2009, Thieme Publishing Group

    Prof. Francisco Marin

  487. Is thrombogenesis related to residual platelet function in ischaemic heart disease?

    Article • European Heart Journal, October 2008, European Society of Cardiology

    Prof. Francisco Marin

  488. Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

    Article • European Heart Journal, September 2008, European Society of Cardiology

    Prof. Francisco Marin

  489. Endothelial protein C receptor polymorphisms and risk of myocardial infarction

    Article • Haematologica, September 2008, Ferrata Storti Foundation (Haematologica)

    Prof. Francisco Marin

  490. Increased Major Bleeding Complications Related to Triple Antithrombotic Therapy Usage in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Artery Stenting

    Article • CHEST Journal, September 2008, Elsevier

    Prof. Francisco Marin

  491. Hypertension, aortic sclerosis and the prothrombotic state: understanding the complex interaction

    Article • Journal of Human Hypertension, August 2008, Springer Science + Business Media

    Prof. Francisco Marin

  492. The impact of statin use on atrial fibrillation

    Article • QJM, July 2008, Oxford University Press (OUP)

    Prof. Francisco Marin

  493. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

    Article • American Heart Journal, July 2008, Elsevier

    Prof. Francisco Marin

  494. Antithrombotic Therapy Use After Percutaneous Coronary Intervention and Stent Implantation in Patients Taking Chronic Oral Anticoagulation

    Article • JACC Cardiovascular Interventions, June 2008, Elsevier

    Prof. Francisco Marin

  495. Variables Associated With Contrast-Enhanced Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy: Clinical Implications

    Article • Journal of Cardiac Failure, June 2008, Elsevier

    Prof. Francisco Marin

  496. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis

    Article • European Heart Journal, May 2008, European Society of Cardiology

    Prof. Francisco Marin

  497. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms

    Article • Haematologica, May 2008, Ferrata Storti Foundation (Haematologica)

    Prof. Francisco Marin

  498. Reply

    Article • Journal of the American College of Cardiology, May 2008, Elsevier

    Prof. Francisco Marin

  499. Premature myocardial infarction: Clinical profile and angiographic findings

    Article • International Journal of Cardiology, May 2008, Elsevier

    Prof. Francisco Marin

  500. Unable to speak—because of a drip

    Article • The Lancet, May 2008, Elsevier

    Prof. Francisco Marin

  501. Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting

    Article • QJM, March 2008, Oxford University Press (OUP)

    Prof. Francisco Marin

  502. Mortality in patients with atrial fibrillation: improving or not?

    Article • EP Europace, March 2008, European Society of Cardiology

    Prof. Francisco Marin

  503. Short- and long-term effects of growth hormone on the heart

    Article • International Journal of Cardiology, March 2008, Elsevier

    Prof. Francisco Marin

  504. Letter by Roldán et al Regarding Article, “Plasminogen Activator Inhibitor-1 as a Predictor of Postoperative Atrial Fibrillation After Cardiopulmonary Bypass”

    Article • Circulation, February 2008, Wolters Kluwer Health

    Prof. Francisco Marin

  505. Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation

    Article • Journal of the American College of Cardiology, February 2008, Elsevier

    Prof. Francisco Marin

  506. Gadolinium-Enhanced Cardiovascular Magnetic Resonance and Exercise Capacity in Hypertrophic Cardiomyopathy

    Article • Revista Española de Cardiología (English Edition), January 2008, Elsevier

    Prof. Francisco Marin

  507. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'

    Article • Thrombosis and Haemostasis, January 2008, Thieme Publishing Group

    Prof. Francisco Marin

  508. Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

    Article • Annals of Medicine, January 2008, Taylor & Francis

    Prof. Francisco Marin

  509. Is There a Role for Levosimendan in Hospital Emergency Departments?

    Article • Revista Española de Cardiología (English Edition), January 2008, Elsevier

    Prof. Francisco Marin

  510. TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction

    Article • Thrombosis and Haemostasis, January 2008, Thieme Publishing Group

    Prof. Francisco Marin

  511. Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy

    Article • Journal of the American College of Cardiology, December 2007, Elsevier

    Prof. Francisco Marin

  512. A multimarker risk stratification approach to non‐ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro‐BNP and fibrin D‐dimer levels

    Article • Journal of Internal Medicine, November 2007, Wiley

    Prof. Francisco Marin

  513. Plasma angiogenin levels in acute coronary syndromes: implications for prognosis

    Article • European Heart Journal, November 2007, European Society of Cardiology

    Prof. Francisco Marin

  514. Respuesta

    Article • Revista Española de Cardiología, July 2007, Elsevier

    Prof. Francisco Marin

  515. Matrix metalloproteinase‐1 and its inhibitor, TIMP‐1, in systolic heart failure: relation to functional data and prognosis

    Article • Journal of Internal Medicine, June 2007, Wiley

    Prof. Francisco Marin

  516. Coronary aneurysms after drug-eluting stents implantation

    Article • European Heart Journal, June 2007, European Society of Cardiology

    Prof. Francisco Marin

  517. Pharmacologic Therapy in Growth Hormone Disorders and the Heart

    Article • Current Medicinal Chemistry, June 2007, Bentham Science Publishers

    Prof. Francisco Marin

  518. Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow‐up after premature myocardial infarction

    Article • Journal of Thrombosis and Haemostasis, April 2007, Elsevier

    Prof. Francisco Marin

  519. Common Carotid Artery Intima-Media Thickness and Intracranial Pulsatility Index in Non-ST-Elevation Acute Coronary Syndromes

    Article • Cerebrovascular Diseases, January 2007, Karger Publishers

    Prof. Francisco Marin

  520. Effect of Statins on Preventing Recurrence of Atrial Fibrillation After Electrical Cardioversion

    Article • The American Journal of Cardiology, November 2006, Elsevier

    Prof. Francisco Marin

  521. Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task

    Article • International Journal of Cardiology, June 2006, Elsevier

    Prof. Francisco Marin

  522. Atrial stunning as predictor of early relapse into atrial fibrillation after cardioversion

    Article • International Journal of Cardiology, June 2006, Elsevier

    Prof. Francisco Marin

  523. Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?

    Article • International Journal of Cardiology, June 2006, Elsevier

    Prof. Francisco Marin

  524. Desfibrilador automático en la miocardiopatía hipertrófica. Experiencia de 3 centros

    Article • Revista Española de Cardiología, June 2006, Elsevier

    Prof. Francisco Marin

  525. Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

    Article • Journal of Thrombosis and Thrombolysis, April 2006, Springer Science + Business Media

    Prof. Francisco Marin

  526. Growth Hormone Therapy and the Heart

    Article • The American Journal of Cardiology, April 2006, Elsevier

    Prof. Francisco Marin

  527. Fluctuations in Coagulation Activity Among Patients with Atrial Fibrillation who are Stably Anticoagulated

    Article • Future Cardiology, February 2006, Taylor & Francis

    Prof. Francisco Marin

  528. Statins and Postoperative Risk of Atrial Fibrillation Following Coronary Artery Bypass Grafting

    Article • The American Journal of Cardiology, January 2006, Elsevier

    Prof. Francisco Marin

  529. Cardiac tamponade following pacemaker implantation

    Article • International Journal of Cardiology, October 2005, Elsevier

    Prof. Francisco Marin

  530. Efecto de dosis máximas de atorvastatina en la inflamación, la trombogénesis y la función fibrinolítica en pacientes con cardiopatía isquémica de alto riesgo

    Article • Revista Española de Cardiología, August 2005, Elsevier

    Prof. Francisco Marin

  531. Polimorfismos en la región Kozak del FXII y su relación con el infarto agudo de miocardio prematuro

    Article • Clínica e Investigación en Arteriosclerosis, June 2005, Elsevier

    Prof. Francisco Marin

  532. Are there ethnic differences in the circadian variation in onset of acute myocardial infarction?

    Article • International Journal of Cardiology, April 2005, Elsevier

    Prof. Francisco Marin

  533. Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation

    Article • The American Journal of Cardiology, April 2005, Elsevier

    Prof. Francisco Marin

  534. Plasma Concentration of Big Endothelin-1 and Its Relation With Plasma NT-proBNP and Ventricular Function in Heart Failure Patients

    Article • Revista Española de Cardiología (English Edition), March 2005, Elsevier

    Prof. Francisco Marin

  535. Influence of smoking habit on cardiac functional capacity and diastolic function in healthy people

    Article • International Journal of Cardiology, February 2005, Elsevier

    Prof. Francisco Marin

  536. Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation

    Article • Thrombosis Research, January 2005, Elsevier

    Prof. Francisco Marin

  537. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction

    Article • Journal of the American College of Cardiology, January 2005, Elsevier

    Prof. Francisco Marin

  538. Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction

    Article • Thrombosis and Haemostasis, January 2005, Thieme Publishing Group

    Prof. Francisco Marin

  539. Effect of factor VII −323 Del/Ins polymorphism on the daily variability of factor VIIc and INR in steady anticoagulated patients with acenocoumarol

    Article • Journal of Thrombosis and Haemostasis, December 2004, Elsevier

    Prof. Francisco Marin

  540. Can We Expect Polymorphisms to Answer our Questions?

    Article • Revista Española de Cardiología (English Edition), November 2004, Elsevier

    Prof. Francisco Marin

  541. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction

    Article • American Heart Journal, October 2004, Elsevier

    Prof. Francisco Marin

  542. Genetic Polymorphisms and Thromoembolic Risk in Atrial Fibrillation

    Article • Journal of Thrombosis and Thrombolysis, October 2004, Springer Science + Business Media

    Prof. Francisco Marin

  543. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation

    Article • Journal of Molecular and Cellular Cardiology, September 2004, Elsevier

    Prof. Francisco Marin

  544. Are we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function

    Article • Journal of Human Hypertension, June 2004, Springer Science + Business Media

    Prof. Francisco Marin

  545. NT-proBNP Levels and Hypertension. Their Importance in the Diagnosis of Heart Failure

    Article • Revista Española de Cardiología (English Edition), May 2004, Elsevier

    Prof. Francisco Marin

  546. Effects of Pretreatment with Intravenous Flecainide on Efficacy of External Cardioversion of Persistent Atrial Fibrillation

    Article • Pacing and Clinical Electrophysiology, March 2004, Wiley

    Prof. Francisco Marin

  547. Hypoxemia and Stroke in a Patient With a Pacemaker

    Article • Revista Española de Cardiología (English Edition), March 2004, Elsevier

    Prof. Francisco Marin

  548. Growth Hormone Therapy , Is it Always Good for the Heart?

    Article • European Heart Journal, January 2004, European Society of Cardiology

    Prof. Francisco Marin

  549. Matrix metalloproteinases in atrial fibrillation

    Article • Journal of the American College of Cardiology, January 2004, Elsevier

    Prof. Francisco Marin

  550. Fractional shortening-velocity ratio for assessment of aortic stenosis severity in patients with systolic dysfunction

    Article • International Journal of Cardiology, December 2003, Elsevier

    Prof. Francisco Marin

  551. NT-proBNP y desplazamiento del plano auriculoventricular. Relación e implicaciones diagnósticas

    Article • Revista Española de Cardiología, November 2003, Elsevier

    Prof. Francisco Marin

  552. Heart valve disease in acromegaly

    Article • International Journal of Cardiology, August 2003, Elsevier

    Prof. Francisco Marin

  553. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation

    Article • European Heart Journal, July 2003, European Society of Cardiology

    Prof. Francisco Marin

  554. Angiogénesis y estatinas, ¿a mayor dosis, mayor beneficio?

    Article • Revista Española de Cardiología, June 2003, Elsevier

    Prof. Francisco Marin

  555. Is Thrombogenesis in Atrial Fibrillation Related to Matrix Metalloproteinase-1 and Its Inhibitor, TIMP-1?

    Article • Stroke, May 2003, Wolters Kluwer Health

    Prof. Francisco Marin

  556. Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction

    Article • The American Journal of Cardiology, May 2003, Elsevier

    Prof. Francisco Marin

  557. Fibrinolytic function and atrial fibrillation

    Article • Thrombosis Research, March 2003, Elsevier

    Prof. Francisco Marin

  558. 1438 Hypercoagulable state detected in atrial fibrillation patients is unrelated to clinical predictors to embolism

    Article • European Heart Journal, March 2003, Elsevier

    Prof. Francisco Marin

  559. 277 Is there quality of life improvement after upgrading to dual-chamber pacing in patients with VVI pacemakers?

    Article • European Heart Journal, March 2003, Elsevier

    Prof. Francisco Marin

  560. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer levels in acute-onset nonrheumatic atrial fibrillation

    Article • Journal of the American College of Cardiology, March 2003, Elsevier

    Prof. Francisco Marin

  561. Valor pronóstico de los niveles séricos del factor de necrosis tumoral alfa en pacientes con insuficiencia cardíaca

    Article • Revista Española de Cardiología, February 2003, Elsevier

    Prof. Francisco Marin

  562. Soluble E-selectin in cardiovascular disease and its risk factors

    Article • Thrombosis and Haemostasis, January 2003, Thieme Publishing Group

    Prof. Francisco Marin

  563. Diurnal variation of international normalised ratio in patients under oral anticoagulation

    Article • Thrombosis Research, December 2002, Elsevier

    Prof. Francisco Marin

  564. Cardiac involvement in Fabry disease

    Article • Acta Paediatrica, November 2002, Wiley

    Prof. Francisco Marin

  565. A common polymorphism in the annexin V Kozak sequence (−1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

    Article • Blood, September 2002, American Society of Hematology

    Prof. Francisco Marin

  566. Prothrombin fragment F1+2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples

    Article • International Journal of Cardiology, June 2002, Elsevier

    Prof. Francisco Marin

  567. Do protein Z levels influence the prothrombotic state in atrial fibrillation?

    Article • Thrombosis Research, May 2002, Elsevier

    Prof. Francisco Marin

  568. Low QRS voltage in cardiac tamponade: a study of 70 cases

    Article • International Journal of Cardiology, April 2002, Elsevier

    Prof. Francisco Marin

  569. The role of tissue plasminogen activator on the progression of the coronary disease

    Article • European Heart Journal, January 2002, European Society of Cardiology

    Prof. Francisco Marin

  570. Anexina V en pacientes supervivientes de un infarto de miocardio prematuro

    Article • Revista Española de Cardiología, January 2002, Elsevier

    Prof. Francisco Marin

  571. Diurnal Variation in the Intensity of Anticoagulation in Atrial Fibrillation

    Article • Stroke, January 2002, Wolters Kluwer Health

    Prof. Francisco Marin

  572. Effect of Factor XIII VAL34LEU Polymorphism on Thrombolytic Therapy in Premature Myocardial Infarction

    Article • Thrombosis and Haemostasis, January 2002, Thieme Publishing Group

    Prof. Francisco Marin

  573. Polimorfismo Val34Leu del factor XIII e infarto de miocardio prematuro

    Article • Revista Española de Cardiología, January 2002, Elsevier

    Prof. Francisco Marin

  574. Infrautilización del tratamiento anticoagulante en pacientes con fibrilación auricular

    Article • Medicina Clínica, January 2002, Elsevier

    Prof. Francisco Marin

  575. Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction

    Article • International Journal of Cardiology, April 2001, Elsevier

    Prof. Francisco Marin

  576. Anticoagulant Therapy Modifies Fibrinolytic Dysfunction in Chronic Atrial Fibrillation

    Article • Pathophysiology of Haemostasis and Thrombosis, January 2000, Karger Publishers

    Prof. Francisco Marin

  577. Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation

    Article • The American Journal of Cardiology, October 1999, Elsevier

    Prof. Francisco Marin

  578. Acute cardiac rupture complicating pre-discharge exercise testing. A case report with complete echocardiographic follow-up

    Article • International Journal of Cardiology, March 1999, Elsevier

    Prof. Francisco Marin

  579. Hypofibrinolysis in atrial fibrillation

    Article • American Heart Journal, December 1998, Elsevier

    Prof. Francisco Marin

  580. Antiplatelet Therapy in Stroke Prevention

    Article • January 1992, Springer Science + Business Media

    Prof. Francisco Marin